Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / *W EXP 11/15/202
-
Total 13F shares
-
154,440
-
Share change
-
+154,440
-
Total reported value
-
$184,602
-
Price per share
-
$0.66
-
Number of holders
-
5
-
Value change
-
+$184,602
-
Number of buys
-
5
Institutional Holders of Medicus Pharma Ltd. - *W EXP 11/15/202 (MDCXW) as of Q4 2024
As of 31 Dec 2024,
Medicus Pharma Ltd. - *W EXP 11/15/202 (MDCXW) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
154,440 shares.
The largest 5 holders included
Anson Funds Management LP, Hudson Bay Capital Management LP, CLEAR STREET LLC, Warberg Asset Management LLC, and UBS Group AG.
This page lists
5
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.